# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Gray zone lymphoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
Status: Recruiting
Last Changed: Jun 02, 2020
First Received: Aug 21, 2017
Disease(s): Non-Hodgkin Lymphoma, Lymphoma, Diffuse Large B-Cell Lymphoma, Gray Zone Lymphoma, Primary Central Nervious System Lymphoma
Intervention(s): Pembrolizumab
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Status: Recruiting
Last Changed: Jun 26, 2020
First Received: Nov 04, 1999
Disease(s): Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma, Anaplastic Large-Cell Lymphoma, Gray Zone Lymphoma
Intervention(s): EPOCH, Rituximab
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
Status: Recruiting
Last Changed: Apr 30, 2020
First Received: Jul 26, 2018
Disease(s): Lymphoma, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Cutaneous Lymphoma, Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis, Cutaneous T Cell Lymphoma, Gray Zone Lymphoma
Intervention(s): ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine, Fludarabine
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Status: Recruiting
Last Changed: Apr 24, 2020
First Received: Dec 19, 2016
Disease(s): Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Lymphoma,Non-Hodgkin, Lymphoma, Hodgkin, Lymphoma, Follicular, Marginal Zone Lymphoma, Large Cell Lymphoma, Mantle-Cell Lymphoma, Gray Zone Lymphoma, Burkitt Lymphoma, High Risk Undifferentiated Acute Leukemia
Intervention(s): Bendamustine, Cyclophosphamide
Locations: The University of Arizona Cancer Center, Tucson, Arizona, United States
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
Status: Recruiting
Last Changed: Jun 30, 2020
First Received: Aug 01, 2018
Disease(s): Non-Hodgkin Lymphoma
Intervention(s): Tisagenlecleucel
Locations: Childrens Hospital Los Angeles, Los Angeles, California, United States
UCSF Medical Center, San Francisco, California, United States
Children s National Health System, Washington, District of Columbia, United States
Childrens Healthcare of Atlanta At Scottish Rite, Atlanta, Georgia, United States
Johns Hopkins Oncology Center ORA, Baltimore, Maryland, United States
... and 27 other locations.